Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05675189 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploring Clinical Trial Experiences of Patients With Migraine

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 26, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jan 2025 to Jan 2026 Start date: Jan 2024 to Jan 2025 · Completion date: Jan 2026 to Jan 2027v3 Show 2 more changesShow less
    • Start date: Jan 2024 to Jan 2025
    • Completion date: Jan 2026 to Jan 2027
  2. Primary completion date: Jan 28, 2024 to Jan 2025 Start date: Jan 28, 2023 to Jan 2024 · Completion date: Jan 28, 2025 to Jan 2026v2 Show 2 more changesShow less
    • Start date: Jan 28, 2023 to Jan 2024
    • Completion date: Jan 28, 2025 to Jan 2026
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical study participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine. People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
Trial Details
NCT Number NCT05675189
Lead Sponsor Power Life Sciences Inc.
Conditions Migraine, Migraine Disorders
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov